AVIMOTIN Trademark

Trademark Overview


On Tuesday, April 28, 2009, a trademark application was filed for AVIMOTIN with the United States Patent and Trademark Office. The USPTO has given the AVIMOTIN trademark a serial number of 79068993. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, April 28, 2019. This trademark is owned by MediGene AG. The AVIMOTIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, l...
avimotin

General Information


Serial Number79068993
Word MarkAVIMOTIN
Filing DateTuesday, April 28, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, April 28, 2019
Registration Number3807191
Registration DateTuesday, June 22, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements


Goods and Servicespharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes
Translation of Words in MarkThe wording "AVIMOTIN" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediGene AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameMediGene AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameMediGene AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Friday, November 29, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 29, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, August 24, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 20, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 28, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 28, 2017INVALIDATION PROCESSED
Wednesday, September 27, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 27, 2017CANCELLED SECTION 71
Monday, June 22, 2015COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, February 12, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 30, 2010FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 30, 2010FINAL DISPOSITION PROCESSED
Wednesday, September 22, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 22, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 25, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 23, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 23, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 23, 2010ASSIGNED TO LIE
Monday, January 25, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 11, 2009REFUSAL PROCESSED BY IB
Wednesday, August 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 24, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 24, 2009REFUSAL PROCESSED BY MPU
Friday, July 24, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 23, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 22, 2009ASSIGNED TO EXAMINER
Tuesday, June 30, 2009APPLICATION FILING RECEIPT MAILED
Friday, June 26, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 25, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB